Is carrier screening the same as NIPT?

No. Carrier screening checks if a parent carries a gene for a recessive disorder (e.g., cystic fibrosis, SMA). NIPT screens for chromosomal abnormalities in the fetus. Both are often offered together as part of a comprehensive prenatal screening panel.

Can genetic testing tell the baby's gender?

Yes, NIPT can determine fetal sex (XX or XY) as early as 10 weeks by detecting Y-chromosome sequences in the mother's blood. This is often included in standard NIPT results.

What is the difference between a screening test and a diagnostic test?

A screening test (like NIPT or first-trimester screening) estimates the risk of a condition. A diagnostic test (like CVS or amniocentesis) provides a definitive yes/no answer. Diagnostic tests are invasive and carry a small risk of miscarriage.

Is carrier screening the same as NIPT?

No. Carrier screening checks if a parent carries a gene for a recessive disorder (e.g., cystic fibrosis, SMA). NIPT screens for chromosomal abnormalities in the fetus. Both are often offered together as part of a comprehensive prenatal screening panel.

Can genetic testing tell the baby's gender?

Yes, NIPT can determine fetal sex (XX or XY) as early as 10 weeks by detecting Y-chromosome sequences in the mother's blood. This is often included in standard NIPT results.

What is the difference between a screening test and a diagnostic test?

A screening test (like NIPT or first-trimester screening) estimates the risk of a condition. A diagnostic test (like CVS or amniocentesis) provides a definitive yes/no answer. Diagnostic tests are invasive and carry a small risk of miscarriage.

What Does Genetic Testing Show in Pregnancy?

Q: What does NIPT show in pregnancy?

NIPT (non-invasive prenatal testing) shows the risk of chromosomal conditions like Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). It can also reveal fetal sex and, in some panels, microdeletions. It is a screening test, not diagnostic.

Discover what genetic testing shows in pregnancy, including NIPT, carrier screening, and diagnostic options. A US guide to prenatal screening in 2026.

Genetic testing in pregnancy shows the likelihood or presence of certain chromosomal conditions, genetic disorders, and fetal sex, helping expectant parents make informed decisions about their prenatal care. In 2026, the most common type—non-invasive prenatal testing (NIPT)—analyzes cell-free DNA from a maternal blood draw to screen for conditions like Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). This guide explains the main types of prenatal genetic tests available in the US, what they reveal, and how they fit into your pregnancy journey.

Understanding the Main Types of Prenatal Genetic Tests

Prenatal genetic testing divides into two broad categories: screening tests and diagnostic tests. Screening tests estimate risk; diagnostic tests provide a definitive answer. Most US pregnancies begin with a screening panel, often including NIPT and carrier screening.

Non-Invasive Prenatal Testing (NIPT)

NIPT, also called cell-free DNA screening, is the most advanced screening option. It measures the relative amount of fetal DNA (fetal fraction) in the mother's blood. A low fetal fraction can sometimes lead to a redraw or further testing. NIPT can detect:

Trisomy 21 (Down syndrome), trisomy 18, and trisomy 13 with high accuracy
Sex chromosome aneuploidies (e.g., Turner syndrome, Klinefelter syndrome)
Fetal sex (XY or XX) as early as 10 weeks
In some panels, microdeletions such as 22q11.2 deletion syndrome

NIPT is not diagnostic; a positive result should be confirmed with chorionic villus sampling (CVS) or amniocentesis.

Carrier Screening

Carrier screening checks if a parent carries a gene for a recessive disorder, such as cystic fibrosis, spinal muscular atrophy (SMA), or fragile X syndrome. This test can be done before or during pregnancy. If both parents are carriers, the chance of the child having the condition is 25%.

First-Trimester Screening and Integrated Screening

First-trimester screening combines a blood test (measuring PAPP-A and hCG) with a nuchal translucency ultrasound. Integrated screening adds a second-trimester blood test (quad screen) for a more accurate risk assessment. These tests screen for Down syndrome, trisomy 18, and neural tube defects.

Diagnostic Tests: CVS and Amniocentesis

Chorionic villus sampling (CVS) and amniocentesis are invasive procedures that analyze fetal cells directly. CVS is performed at 10–13 weeks, amniocentesis at 15–20 weeks. Both can diagnose chromosomal abnormalities and genetic disorders definitively, but carry a small risk of miscarriage. A genetic counselor can help you weigh the risks and benefits.

What Results Can You Expect?

Results vary by test type. Here is a quick comparison:

Test Type	What It Shows	When Available	Result Type
NIPT (cell-free DNA)	Risk of trisomies, sex chromosome issues, fetal sex	From 10 weeks	Screening (risk score)
Carrier screening	Carrier status for recessive disorders	Anytime (pre-conception or during pregnancy)	Carrier or non-carrier
First-trimester screening	Risk of Down syndrome, trisomy 18, neural tube defects	11–14 weeks	Screening (risk score)
Quad screen	Risk of Down syndrome, trisomy 18, neural tube defects	15–20 weeks	Screening (risk score)
CVS / Amniocentesis	Definitive diagnosis of chromosomal or genetic conditions	CVS: 10–13 wks; Amnio: 15–20 wks	Diagnostic (yes/no)

Important Considerations for US Parents in 2026

Insurance and Access

Most US insurance plans cover NIPT for high-risk pregnancies (maternal age 35+, abnormal ultrasound, or family history). Carrier screening is often covered once per pregnancy. Diagnostic tests like CVS and amniocentesis may require prior authorization. A genetic counselor can help navigate these steps.

Accuracy and Limitations

NIPT has a detection rate over 99% for trisomy 21, but false positives can occur. The positive predictive value depends on the condition's prevalence. For example, a positive NIPT for a rare microdeletion may have a lower chance of being a true positive. Always confirm with a diagnostic test if a screening result is positive.

Prenatal Paternity Test

Some labs offer a prenatal paternity test using cell-free DNA, which can be performed from 9 weeks. This is a separate test from standard NIPT and is not part of routine prenatal screening panels.

Making Your Decision

Speak with your healthcare provider or a genetic counselor to choose the right tests for your situation. The American College of Obstetricians and Gynecologists recommends offering NIPT to all pregnant individuals, regardless of age. Carrier screening is also recommended for all who are planning a pregnancy or are already pregnant.

If you are ready to take the next step, you can order a comprehensive prenatal screening panel online and get results quickly—no waiting for an office visit. Order a prenatal screening panel online to gain clarity and peace of mind early in your pregnancy.